New slurried chromatography resins eliminate resin hydration step to help accelerate downstream purification of oligonucleotides and peptides WILMINGTON, Del. — DuPont (NYSE:DD) today announced the launch of DuPont™ AmberChrom™ XT20 SL and XT30 SL chromatography resins, expanding its bioprocessing portfolio to help manufacturers streamline purification operations for oligonucleotide and peptide therapeutics. Oligonucleotide and peptide therapeutics […]

Delivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3 Achieves 10x improvement in absolute molar mass and extended sizing, without compromising resolution or analytical throughput.2 Reduces sample consumption by 30-50% and solvent use by approximately 40%.3 MILFORD, Mass. — Waters Corporation (NYSE: WAT) today announced the launch of the […]

Collaboration supports global LRRK2 Investigative Therapeutics Exchange (LITE) to accelerate development of reliable biomarkers for Parkinson’s disease ZURICH, Switzerland – Biognosys Group, a leading provider of proteomics, metabolomics, and lipidomics solutions, today announced a major collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to advance the development of highly sensitive and quantitative […]

COLUMBIA, Md. — Shimadzu Scientific Instruments introduces the Nexis GC-2060 gas chromatograph, the latest evolution of Shimadzu’s flagship GC platform. Designed to maximize uptime, streamline workflows and improve laboratory efficiency, the Nexis GC-2060 delivers enhanced support for both routine and evolving analyses. The Nexis GC-2060 is designed for research and development and quality control analyses across […]

WHAT: Waters Corporation (NYSE: WAT) has introduced next-generation Acquity™ and XBridge™ Biphenyl Liquid Chromatography Columns with MaxPeak™ Premier Technology, designed to deliver enhanced aromatic selectivity with exceptionally low UV bleed and robust, wide-range pH stability. Built on Waters’ trusted Ethylene Bridged Hybrid (BEH™) Hybrid Particle Platform and paired with inert MaxPeak Premier Technology, these columns provide reliable, reproducible performance across LC and LCMS workflows for small molecule pharmaceutical method development, bioanalytical, and food and environmental applications. The new Biphenyl columns […]

WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region’s most ambitious and diverse population-scale biobank initiatives. The collaboration reflects growing investments from national population studies looking to harness proteomics […]

Seer’s Proteograph will be used to generate enhanced proteomic insights in one of the world’s largest multi-omic health studies REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Proteograph® Product Suite, has been selected as the mass spectrometry-based proteomic workflow to deeply profile the […]

MilliporeSigma strengthens downstream purification with Protein A chromatography, boosting scalable manufacturing and speeding therapy access. Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing Integrated downstream workflows to improve productivity and help speed access to critical therapies Burlington, Massachusetts, United States of America — MilliporeSigma, the U.S. and Canada Life Science business […]

BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry executive with decades of relevant leadership, strategic and operational experience. Thierry Bernard Frank H. Laukien, the Chairman, President and CEO […]

US PTAB Revokes Sole Independent and Other Central Claims of U.S. Patent 11,435,360 SCHLIEREN, Switzerland & MUNICH — PreOmics GmbH and Biognosys AG today announced a favorable outcome in an inter partes review (IPR) proceeding IPR2024‑01473 before the U.S. Patent Trial and Appeal Board (PTAB). The PTAB has revoked the central claims of U.S. Patent […]